About Telix Pharmaceuticals (AMER)
See it. Treat it.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- North Melbourne, Victoria
- Founded
- 2015
- Company type
- Public Company
- Company profile name
- Telix Pharmaceuticals Limited
Telix is a global biopharmaceutical company focused on the development and commercialization of radiopharmaceuticals to address significant unmet medical need in oncology and rare diseases. Headquartered in Melbourne, Australia, Telix operates internationally and is listed on the ASX and Nasdaq under the ticker TLX.
Specialties
- Radiology
- Prostate Cancer
- Renal Cancer
- Glioblastoma
- Positron Emission Tomography
- Nuclear Medicine
- Molecularly Targeted Radiation
- Urology
- Molecular Imaging
- Cancer Imaging
- and Cancer Therapy
Company locations
55 Flemington Rd, North Melbourne, Victoria 3051, AU
Locations on the company profile may be outside this area. Not every location is hiring.
Business areas
- Biotechnology
- Biotech & Pharmaceuticals
- Pharmaceutical and biotechnology
On LinkedIn
- Followers
- 72,423
- People linked to this company
- 1,213
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
1,093,273,377 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.